trypsin inhibitor BGIT, Momordica charantia

Known as: BGIT trypsin inhibitor, Momordica charantia 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2017
012319862017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The present study was undertaken to investigate the hepatoprotective effect of Momordica charantia in alloxan induced diabetic… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2014
2014
Diabetes, a common metabolic disorder, is characterized by hyperglycemia. Insulin is the principal mediator of glucose… (More)
Is this relevant?
2013
2013
Momordica charantia (MC) has been used as an alternative therapy for diabetes mellitus. This study analyzed and elucidated… (More)
Is this relevant?
2009
2009
The present study was undertaken to determine the interaction of rosiglitazone, a PPAR-gamma agonist with methanolic extract of… (More)
  • figure 1
  • figure 5
Is this relevant?
2009
2009
AIM Diabetic liver is associated with biochemical, physiological and pathological changes. The aim of the present study was to… (More)
Is this relevant?
2009
2009
Momordica charantia, commonly known as karela or bitter melon, is used as a vegetable in Chinese, Indian subcontinent. However… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
To examine the effects of Momordica charantia on glucose uptake and adiponectin secretion in adipose cells, 3T3-L1 adipocytes… (More)
Is this relevant?
1994
1994
The effect of Momordica charantia on certain key hepatic enzymes was investigated using male Sprague-Dawley rats as the animal… (More)
Is this relevant?
1987
1987
Ginsenosides Rb1, Rb2, Rc and Rg1 inhibited steroidogenesis induced by a maximally active dose of corticotropin in isolated rat… (More)
Is this relevant?
1986
1986
The extra pancreatic effects of the oral hypoglycaemic plant Momordica charantia have been investigated in rats. It was found… (More)
Is this relevant?